BridgeMD
Compares treatment options for Hemodialysis
Official title Comparing Reticulocyte Hemoglobin and Transferrin Saturation to Guide Iron Treatment in People on Dialysis
ClinicalTrials.gov ID: NCT06906835
What this study is testing
- What it's testing
- The goal of this clinical trial is to find out which method is better for guiding iron treatment in adult patients with end-stage kidney disease (ESKD) on hemodialysis who have anemia. The main questions it aims to answer are: Can using reticulocyte hemoglobin equivalent (RET-He) to guide intravenous (IV) iron treatment be as effective as using transferrin saturation (TSAT)?
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 to 80
You may be able to join if
- Adult (age 18-80 years)
- ESKD on chronic hemodialysis ≥ 6 months
- EPO therapy ≥ 6 months
- Hb \< 13.0 g/dL in male, \< 12.0 g/dL in female
You likely can't join if
- Serum ferritin \> 800 ng/mL or TSAT \> 40%
- Active infection or malignancy
- Hematologic disease including thalassemia major, hemolysis, myelofibrosis or myelodysplastic disease
- History of marrow suppressive or immunosuppressive medications in past 6 months
- History of active heart failure and recent myocardial infarction /stroke in past 6 months
- History of GI or external bleeding or receiving blood transfusion in past 6 months
The study team makes the final eligibility decision.
Where it's taking place
- Pathumwan, Bangkok, Thailand
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years to 80 years. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Pathumwan, Bangkok, Thailand. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.